Riskpilot← Back to searchSign inGet full accessKATLE ØRE-NESE-HALS AS
ASActiveOrg 926490796Boganesveien 10, 4020 StavangerMedical specialists activities · NACE 8622Est. 20215 employees
Revenue 2025
NOK 9,1M
-14% vs 2024
EBITDA margin
43.9%
-27% vs 2024
Equity ratio
2.1%
Financial strength
Net profit 2025
NOK 2,7M
-23% vs 2024
| Revenue | NOK 9,1M | -14% |
| EBITDA | NOK 4M | -27% |
| Net profit | NOK 2,7M | -23% |
| Total assets | NOK 5,2M | -16% |
| Equity | NOK 111K | -7% |
| Employees | 5 | — |
Legal name
KATLE ØRE-NESE-HALS AS
Org number
926490796
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. januar 2021
Share capital
NOK 70 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet i privat spesialisthelsetjeneste. Herunder undervisning, foredrag og medisinsk forskning samt å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Boganesveien 10, 4020 Stavanger
Phone
+4751883500
Email
post@stavangeronh.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 193 | 6 759 | 7 897 | 10 646 | 9 111 |
| Staff expenses | −2 004 | −2 367 | −2 670 | −3 731 | −3 666 |
| EBITDA | 1 978 | 3 134 | 3 608 | 5 451 | 4 003 |
| Depreciation & amort. | −505 | −790 | −883 | −848 | −537 |
| EBIT | 1 473 | 2 345 | 2 725 | 4 603 | 3 466 |
| Net financials | −22 | −57 | −37 | −22 | 53 |
| Profit before tax | 1 452 | 2 288 | 2 689 | 4 581 | 3 519 |
| Tax | 317 | 503 | 650 | 1 077 | 828 |
| Net profit | 1 135 | 1 784 | 2 038 | 3 504 | 2 691 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 517 | 4 933 | 5 635 | 6 185 | 5 225 |
| Equity | 1 194 | 1 478 | 116 | 120 | 111 |
| Long-term debt | 2 609 | 1 003 | 925 | 825 | 725 |
| Short-term debt | 714 | 2 453 | 4 594 | 5 239 | 4 388 |
| Total debt | 3 323 | 3 456 | 5 519 | 6 064 | 5 113 |
EBITDA margin
43.9%
This company
15.8%
Market median
+178% vs market
20212025
Equity ratio
2.1%
This company
38.2%
Market median
-95% vs market
20212025
Return on equity
2414.6%
This company
18.4%
Market median
+13023% vs market
20212025
Net profit margin
29.5%
This company
8.1%
Market median
+264% vs market
20212025
Asset turnover
1.74×
This company
1.12×
Market median
+55% vs market
20212025
Debt / equity
45.87×
This company
0.62×
Market median
-7298% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
E- Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Katle - Holding As
KATLE ØRE-NESE-HALS AS Board members of KATLE ØRE-NESE-HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin - Johanne Katle | Chief Executive Officer | 0 companies |
| Knut Tore Fjon | Board of Directors | 0 companies |